Latest News

Date Title Topic
03 Apr 2014 Genetic Mutations Predispose to Familial Melanoma Pathology/Molecular biology - Melanoma
03 Apr 2014 When to Consider Doxorubicin Alone or in Combination With Ifosfamide for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma? Sarcomas - Anticancer agents & Biologic therapy
02 Apr 2014 Next Generation ALK Inhibitor for ALK-Rearranged Non–Small Cell Lung Cancer Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
01 Apr 2014 PRESTIGE Study: Goserelin Given Every 12 vs. 4 Weeks in Premenopausal Women With ER-Positive Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
31 Mar 2014 Global Opioid Access: WHO accelerates the pace, but we still need to do more
28 Mar 2014 ELCC 2014 News: Cabazitaxel Fails to Meet the Primary Endpoint in a Randomised Phase II Study in SCLC Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Mar 2014 ELCC 2014 News: Clinical Utility of miRNA Signature in Plasma of Smokers Included in LD-CT Lung Cancer Screening Cancer prevention - Translational research - Lung and other thoracic tumours
28 Mar 2014 ELCC 2014 Press Release: Call for More Awareness of Sexual Dysfunction in Lung Cancer Patients Lung and other thoracic tumours
27 Mar 2014 ELCC 2014 News: Mutational Spectrum of Patients Enrolled Into GALAXY-1 Study Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: A Meta-Analysis of Platinum-Based vs. Single Agent Chemotherapy in NSCLC Patients with Performance Status 2 Cancer in Special Situations - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Salvage Therapy With Paclitaxel and Bevacizumab in Patients with Refractory Relapsed SCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: Efficacy and Safety of Targeted Therapy in Elderly Patients With Lung Cancer Adenocarcinoma Cancer in Special Situations - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Mar 2014 ELCC 2014 News: PD-L1 Expression and Association with Survival in Mesothelioma Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: PD-L1 and PD-1 Expression in a Cohort of Molecularly Selected NSCLC Patients Pathology/Molecular biology - Lung and other thoracic tumours - Immuno-oncology
27 Mar 2014 ELCC 2014 News: Diagnosis and Targeting Lung Adenocarcinoma with RET Fusion Pathology/Molecular biology - Lung and other thoracic tumours - Anticancer agents & Biologic therapy